Introduction
In previous studies, the expression of C-CAM was shown to be lost or signi®cantly reduced in carcinomas of the liver (Hixson and McEntire, 1989; Hixson et al., 1985) , prostate and colon (Neumaier et al., 1993; Rosenberg et al., 1993) . C-CAM down regulation was also demonstrated during the early stages of carcinogenesis in rat liver and human prostate. These observations suggested that down regulation of C-CAM might be an essential step in the acquisition of the malignant phenotype. Consistent with this notion, we have recently shown that down-regulation of C-CAM in non-tumorigenic NbE prostate epithelial cells by transfection of a C-CAM1 (the isoform with the full length 71 amino acid cytoplasmic domain) antisense vector made these cells capable of forming tumors in nude mice while transfection of a C-CAM1 sense vector into PC-3 prostate carcinoma cells signi®cantly suppressed their tumorigenicity .
Although C-CAM1 can function as a growth suppressor, its mechanism of action is largely unresolved. C-CAM1 has sequence homology with carcinoembryonic antigen (Aurivillius et al., 1990; Lin et al., 1991) . As predicted from its cDNA sequence, C-CAM1 contains four extracellular Ig-like domains, a transmembrane domain, and a cytoplasmic domain. By site-directed mutagenesis, we have shown that the ®rst Ig-domain is essential for adhesion, whereas the second, third, and fourth Ig-domains and the cytoplasmic domain are not (Cheung et al., 1993b; Lin et al., 1995; Olsson et al., 1995) . The fact that C-CAM1 has both cell-adhesion and growth-suppressive activities suggests that these two functions may be related. However, we have found that the tumor suppressive activity of C-CAM1 requires its cytoplasmic domain (Luo et al., 1997) but not the ®rst Ig domain suggesting that a signal-transduction pathway involving interactions with other membrane or cytoplasmic proteins is required for outside in or inside out signaling. Identi®cation of these C-CAM associated proteins will be critical for understanding how C-CAM1 inhibits the growth of tumor cells.
Chemical cross-linking is a powerful tool for investigating dynamic protein interactions. Bifunctional cross linkers can stabilize complexes between proteins by forming covalent bridges between directly associated or neighboring proteins. For intermolecular cross linking, the protein complexes must also have long enough half-lives for these two steps to occur.
Cross-linking can thus provide snap shots of protein complexes that might not associate tightly enough to be detected by other methods. In the present study, we have chosen to use bifunctional crosslinkers and immunoprecipitation to isolate complexes between C-CAM1 and an 80 kDa protein, designated CAP-80. Using a series of C-CAM1 mutants with deletions in the extracellular or cytoplasmic domain, we show that CAP-80 binding requires the C-terminal half of the C-CAM1 cytoplasmic domain.
Results

Eects of detergents on the association of proteins with C-CAM
Since the eects of detergent on the stability of complexes between C-CAM and its associated proteins was not known, cross-linking was performed on plasma membrane proteins solubilized in detergents that diered in structure, micellar size and charge (nonionic detergents: Triton X-100, Brij 35, Brij 58, Tween 20; ionic detergent sodium cholate, and Zwittergen 3 ± 14). WGA puri®ed proteins from each detergent extract were cross-linked with the bifunctional cross-linker, DSS or DSG. When reacted with Western blots prepared from membranes solubilized with Triton X-100, Tween 20, Zwittergent 3 ± 14, or Brij 58 (Figure 1 ), Ab669 detected two components, a broad 100 kDa C-CAM band and an additional higher molecular weight band of approximately 180 kDa. This 180 kDa band was only detected in cross-linked extracts, suggesting that treatment with DSS or DSG had stabilized complexes between C-CAM and an 80 kDa protein, designated CAP-80 (C-CAM associated protein). Levels of the 180 kDa complex varied depending on the detergent used for solubilization. Among the six detergents tested, Triton X-100 was the best in preserving the association between CAP-80 and C-CAM (Figure 1 ). In contrast, no complexes were detected in membrane extracts prepared with sodium cholate or Brij 35.
Immunoprecipitation analysis
Although cross-linking analysis suggested an association between C-CAM and an 80 kDa protein (CAP-80), the possibility that the 180 kDa immunoreactive band represented a complex between C-CAM and one or more low molecular weight peptides could not be excluded. To examine this possibility, immunoprecipitation analysis was carried out using WGA puri®ed proteins from rat liver membranes solubilized in Triton X-100, the detergent that preserved the highest level of complexes in cross-linking experiments. When proteins immunoprecipitated with Ab669 were analysed by SDS ± PAGE and visualized by silver stain, a protein of 80 kDa was detected in immunocomplexes ( Figure 2 , Lane 1). This 80 kDa protein was not detected when C-CAM was ®rst depleted with Ab669 ( Figure 2 , Lane 2), suggesting the co-precipitation of CAP-80 was due to its speci®c association with C-CAM and was not the result of crossreactivity with Ab669 or nonspeci®c binding to protein G. The molecular mass of this protein is consistent with that from cross-linking studies, suggesting that the same protein is detected by these two approaches.
Cross-linking of C-CAM1 with CAP-80
Results from cross-linking and immunoprecipitation suggest that CAP-80 associates with C-CAM in a speci®c manner. To investigate the site of interaction between C-CAM1 and CAP-80, the ability of various C-CAM1 mutants to form complexes with CAP-80 was investigated in Sf9 cells using baculovirus vectors encoding C-CAM1 with truncations in the extracellular Ig-like domains or the cytoplasmic domain. In our previous study, we found that expression of C-CAM1 in Sf9 cells conferred cell adhesion activity to these cells, suggesting that C-CAM1 expressed in Sf9 cells was functional (Cheung et al., 1993b) .
When expressed in insect cells, C-CAM1 exhibits a molecular mass (75 ± 80 kDa) that is signi®cantly smaller than that (100 kDa) observed in rat liver plasma membranes. The dierence is resulted from . By subtracting the molecular mass of C-CAM1 from 160 kDa, the apparent molecular mass of the associated protein was estimated to be 80 kDa, similar to that of the associate protein from rat liver membrane preparation. This result suggests that a homologue of CAP-80, designated ICAP-80 is present in insect cells. The amount of the cross-linked ICAP-80/C-CAM1 complex is less than that of CAP-80/C-CAM1 complex. In an attempt to increase the amount of the cross-linked C-CAM1-associate protein complex, we examined the amount of the 160 kDa protein detected after crosslinking from 0 ± 30 min. As shown in Figure 3 , the 160 kDa signal was not increased by increasing the time of the cross-linking. In fact, a slight decrease of the cross-linked complex was seen with longer incubation time. This decrease could be due to the formation of larger aggregates as a result of excess cross-linking or as a result of proteolysis. Thus, the dierence between the amounts of the cross-linked CAP-80/C-CAM1 and the ICAP-80/C-CAM1 complexes is probably due to dierent amounts of CAP-80 and ICAP-80 available for cross-linking in these two systems. It is also possible that C-CAM1 is overexpressed in the insect cells such that ICAP-80 becomes limiting.
Adhesion activity and ICAP-80 association
In a previous study we demonstrated that the ®rst Ig domain of C-CAM1 but not the second, third or fourth domain was required for adhesion activity (Cheung et al., 1993b) . To determine whether any of the Ig domains were required for association with ICAP-80, we performed cross-linking experiments using C-CAM1 mutants with deletions in the extracellular Ig-domains ( Figure 4a ). Each Ig domain deletion is expected to decrease the apparent molecular mass of C-CAM1 by 10 ± 15 kDa (Cheung et al., 1993b) due to dierent degrees of glycosylation. As shown in Figure 4b , in addition to the band expected for C-CAM1 or its mutant (around 70 kDa), an Ab669-reactive band around 150 kDa was detected by immunoblot analysis in each cell lysate after crosslinking with DSS. These larger species presumably arose from cross-linking of C-CAM1 or its mutants with ICAP-80. This result suggests that deletion of the extracellular Ig domains does not aect their association with ICAP-80 and adhesion activity is not required for the association between C-CAM1 and ICAP-80.
Localization of C-CAM1 sequences in the cytoplasmic domain that are critical for ICAP-80 binding
The cytoplasmic domain of C-CAM1 contains 71 amino acids that are encoded by four exons, i.e., exons 6 ± 9 (Cheung et al., 1993a; Najjar et al., 1993) . The membrane-proximal 6 amino acids together with the transmembrane domain is encoded by exon 6, while the rest of the cytoplasmic sequence was encoded by exons 7, 8 and 9 (each with 18, 10 and 35 amino acids, respectively). To identify the site of ICAP-80 binding, we tested the ability of ICAP-80 to complex with various mutants containing deletions in one or more of the exons encoding the cytoplasmic domain of C- C-CAM1 associated protein W Luo et al CAM1 (Figure 5a ). Immunoblot results shown in Figure 5b indicate that CAP-80 was not cross-linked with CAM1-H458, a deletion mutant which lacks the C-terminal 61 amino acids of the cytoplasmic domain encoded by exons 7 ± 9, thereby con®rming that the ICAP-80 site of interaction resides in the cytoplasmic domain. Complexes of ICAP-80 and C-CAM1 were also not detected in lysates from cells infected with mutants lacking exons 8 and 9 (CAM1-K472) or exon 9 (CAM1-N482), suggesting that the subdomain encoded by exon 9 might be critical for ICAP-80 association.
Secondary structure analysis by combined nearestneighbor algorithms and multiple sequence alignments (Salamov and Solovyev, 1995) predicts that with exception of two short stretches of b strands at amino acid 486 ± 492 and 511 ± 517, the remainder of the C-CAM1 cytoplasmic domain lacks de®ned secondary structure. Interestingly, the cytoplasmic domains of C-CAM1 homologues from human and mouse are also predicted to have identical secondary structure arrangement. These two potential b strands which may interact with each other in a parallel or antiparallel fashion are encoded by exon 9, the site of ICAP-80 binding. It To test this hypothesis, we constructed mutant CAM1-K499, which lacks half of the exon 9 encoded sequence (18 amino acid). We found that association between CAP-80 and mutant CAM1-K499 was markedly reduced (Figure 5b ) and sometimes undetectable (data not shown), lending support for the importance of the bloop-b structure in ICAP-80 binding.
Tyrosine phosphorylation and ICAP-80 association
The cytoplasmic domain of C-CAM1 contains several potential phosphorylation sites, including putative consensus sequences for cAMP-dependent kinase and tyrosine kinase . One of these potential tyrosine phosphorylation sites (Tyr488) is located at the 5' end of exon 9 within a partial antigen-receptor homology motif (ITAM/ITIM) (Cambier, 1995) . This phosphorylation site also resides within the ®rst b strand at the 5' end of exon 9. Phosphorylation of ITAM/ITIM motifs is involved in membrane-bound IgM signal transduction in B cells (Cambier and Campbell, 1992) . In vivo, C-CAM1 could be phosphorylated on Tyr488 , raising the possibility that phosphorylation at this site might be important for ICAP-80 binding. To examine this possibility, cross-linking was performed with lysate from cells expressing a mutant C-CAM1 in which this tyrosine is replaced by phenylalanine (i.e., CAM1-F488). As shown in Figure 5b , substituting Phe for Tyr488 did not abolish the interaction between C-CAM1 and CAP-80, suggesting that phosphorylation at Tyr488 is not required for ICAP-80 binding.
Discussion
Results from the present studies suggest that an 80 kDa protein in liver and insect cells, designated CAP-80 or ICAP-80 respectively, associates with a region of the C-CAM1 cytoplasmic domain known to be essential for growth suppression. This was suggested by the lack of complex formation in cells expressing mutants missing the last 61 amino acids of the cytoplasmic domain. We have previously observed that this region of the cytoplasmic domain is critical for tumor suppressor activity. Results from more detailed deletion mapping indicated that the ICAP binding site was located within the C-terminal 35 amino acids of the cytoplasmic domain, the subdomain encoded by exon 9. This particular region is predicted to have two stretches of b strands, a secondary structure that is conserved in the human and mouse homologues to C-CAM1. The high degree of conservation across species suggest that the function of this domain as a CAP-80 binding site may also be conserved.
Our results also show that the association between ICAP-80 and C-CAM1 does not require adhesion activity. Deletion of the ®rst Ig domain of C-CAM1 which is critical for adhesion had no eect on ICAP-80 association. Conversely, deletion of the cytoplasmic domain did not alter adhesion but did abolish ICAP-80 binding. This suggests that adhesive interactions mediated by the ®rst Ig domain are not required for either ICAP-80/CAP-80 binding or tumor suppression. Alternatively, removal of the ®rst Ig domain could mimic activation induced by adhesion, resulting in constitutive binding of ICAP-80/CAP-80 by a mechanism analogous to the constitutive activation of the tyrosine kinase activity of Erb B, an EGF receptor homologue, that lacks the extracellular ligand binding domain. Regardless of the actual mechanism, the fact that the eects of deletions in the ®rst Ig loop and the cytoplasmic domain on tumor suppressor activity closely parallel those observed for ICAP-80 binding strongly implicate a role for ICAP-80/CAP-80 in the growth suppressive eects of C-CAM1. A direct proof that CAP-80 is involved in suppression will require the isolation of a cDNA encoding CAP-80 which can be used for down regulation of CAP-80 by antisense strategies, an approach we have previously used successfully to demonstrate the tumor suppressive eects of C-CAM1 .
Phosphorylation by tyrosine kinases is a central step in many signal transduction pathways. The presence of a partial ITAM/ITIM motif (Cambier, 1995) in the C-CAM1 cytoplasmic domain, a motif that is a critical site for tyrosine phosphorylation in other Ig-like proteins involved in antigen recognition, suggest that tyrosine phosphorylation could play a role in C-CAM1 signal transduction. However, replacement of Tyr488, a known C-CAM1 phosphorylation site within this motif, with phenylalanine, had no eect on either ICAP-80 association or the tumor suppressive activity of C-CAM1, suggesting that phosphorylation at this site is not required for ICAP-80 binding. However this does not exclude a role for Tyr488 in signal transduction or in CAP-80/ ICAP-80 binding since it is equally likely that phosphorylation could inhibit rather than enhance binding. Previous pulse chase studies indicated that C-CAM1 was rapidly dephosphorylated in vitro, making likely that most of the Tyr488 residues might be dephosphorylated in extracts prepared without phosphatase inhibitors, thereby allowing complex formation to occur at higher levels than what is normally present in plasma membrane in situ. Besides Tyr488, C-CAM1 is also known to be phosphorylated at Ser503 (Najjar et al., 1995) . In this study, mutant CAM1-K499 was found to lose most of its ability to associate with ICAP-80. This loss of ICAP-80 binding could be due to disruption of the predicted b-loop-b structure. However, it is equally likely that this loss of ICAP-80 binding is due to deletion of the binding site involving the phosphorylated Ser503. If so, phosphorylation at Ser503 may play a role in C-CAM1 function; hence, it should be interesting to see if this phosphorylation is required for the growth suppressive activity of C-CAM1.
The ability to isolate C-CAM1/CAP-80 complexes from membrane extracts following WGA anity chromatography suggest that the anity of CAP-80 for C-CAM1 must be relatively high. However, the stability of these complexes varied signi®cantly among the various detergent used for extraction, a phenomenon observed previously in co-precipitation studies aimed at identifying accessory proteins and kinases associated with the T-cell receptor and membrane bound IgM. In addition to CAP-80, annexin VI and calmodulin have also been shown to form complexes with C-CAM1 (Edlund et al., 1996; Lim, 1990) . Isoforms with both long and short cytoplasmic domain can bind calmodulin in a calcium dependent fashion, suggesting the primary binding site must be proximal to the transmembrane domain (Edlund and Obrink, 1993) . Binding of calmodulin to the membrane proximal region was recently demonstrated using synthetic peptides corresponding to sequences within the C-CAM cytoplasmic domain (Edlund et al., 1996) . The main site of ICAP/CAP-80 binding, in contrast, appears to be within the C-terminal half of the cytoplasmic domain encoded by exon 9. These dierences in binding regions and the marked dierences in between the sizes of ICAP-80/CAP-80 and calmodulin and annexin VI suggest that ICAP-80/ CAP-80 is a distinct protein.
Materials and methods
Plasma membrane preparation and solubilization
Rat liver plasma membranes were prepared as described by Neville (1968) . Plasma membranes were solubilized by incubation for 30 min in 50 mM HEPES, pH 7.4, containing Triton X-100, sodium cholate, Brij 35, Tween 20, Brij 58, or Zwittergent 3 ± 14. A detergent-to-protein ratio (w/w) of 5 was used. Unsolubilized material was removed by centrifugation at 30 000 g for 30 min. The detergent extract was puri®ed by chromatography through a WGA anity column, and the glycoproteins were eluted with 0.3 M N-acetylglucosamine (Sigma Chemical Co., St. Louis, USA) in 50 mM HEPES, pH 7.4 containing 0.1% of detergent.
Cross-linking reactions
To chemically cross-link C-CAM with its interacting proteins, cross-linker (DSS or DSG) (Pierce Chemical Co. Rockford, Il, USA), freshly dissolved in dimethyl sulfoxide, was added at a ®nal concentration of 1 mM to the WGA anity-puri®ed rat liver membrane proteins or to Sf9 cell lysates. The reactions were allowed to proceed at room temperature for 5 min, unless otherwise indicated, before they were stopped by addition of 1 M ammonium chloride.
Immunoprecipitation of C-CAM1 associated proteins
To identify proteins associated with C-CAM1, immunoprecipitation was performed with Triton X-100 solubilized proteins. Liver plasma membranes isolated from 10 rat livers were solubilized in Triton X-100 (detergent to protein ratio (w/w) of 5 : 1), and C-CAM and other membrane glycoproteins were isolated by chromatography on immobilized WGA. C-CAM and associated proteins were immunoprecipitated from the WGA-bound fraction with Ab669, a rabbit antiserum that recognize the two major isoforms in rat liver with long (C-CAM1) and short (C-CAM2) cytoplasmic domains. Immunoprecipitation was carried out by adding 40 ml of protein G-Sepharose (Pharmacia Biotech, Uppsala Sweden) and 5 ml of Ab669 to 10 ml of WGA puri®ed proteins. After a 16 h incubation at 48C with constant stirring, protein G-Sepharose beads containing bound immune complexes were collected by centrifugation. The supernatant was removed and immunoprecipitated a second time with Ab669 in the same manner. Beads from the ®rst and the second immunoprecipitation were washed several times in 50 mM HEPES, pH 7.4, containing 0.1% Triton X-100. Bound proteins eluted by boiling in SDS-sample buer were subsequently analysed by SDS ± PAGE and visualized by silver stain.
Expression of C-CAM1 mutants in insect cells
Cloning of the full-length C-CAM1 cDNA into a baculoviral expression vector has been described previously (Cheung et al., 1993b) . The extracellular deletion mutants DD1, DD2, DD3, and DD4, in which individual Ig-domains were deleted, were constructed as described previously (Cheung et al., 1993b) . Expression vectors containing C-CAM1 cDNAs with mutations or deletions in the cytoplasmic domain (CAM1-F488, CAM1-K499, CAM1-K482, CAM1-N472, and CAM1-H458) were constructed as described . Recombinant viruses encoding C-CAM1 and C-CAM1 mutant proteins were generated and used to infect Sf9 cells as previously described (Cheung et al., 1993b) . Seventy-two hours after infection, the cells were pelleted by centrifugation in a microfuge for 30 s and lysed in distilled water.
Western blotting
Western immunoblot analysis was performed as previously described with Ab669 .
Abbreviations
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